These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 28917272)

  • 1. Towards personalized medicine of colorectal cancer.
    Aziz MA; Yousef Z; Saleh AM; Mohammad S; Al Knawy B
    Crit Rev Oncol Hematol; 2017 Oct; 118():70-78. PubMed ID: 28917272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.
    Xu Z; Li W; Dong X; Chen Y; Zhang D; Wang J; Zhou L; He G
    Clin Chim Acta; 2024 Jun; 559():119686. PubMed ID: 38663471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker Profile of Colorectal Cancer: Current Findings and Future Perspective.
    Hoseini SH; Enayati P; Nazari M; Babakhanzadeh E; Rastgoo M; Sohrabi NB
    J Gastrointest Cancer; 2024 Jun; 55(2):497-510. PubMed ID: 38168859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omics technologies for improved diagnosis and treatment of colorectal cancer: Technical advancement and major perspectives.
    Dalal N; Jalandra R; Sharma M; Prakash H; Makharia GK; Solanki PR; Singh R; Kumar A
    Biomed Pharmacother; 2020 Nov; 131():110648. PubMed ID: 33152902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Omic Layers to Personalized Medicine in Colorectal Cancer: The Road Ahead.
    Romero-Garmendia I; Garcia-Etxebarria K
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized treatment for colorectal cancer: novel developments and putative therapeutic strategies.
    Akkad J; Bochum S; Martens UM
    Langenbecks Arch Surg; 2015 Feb; 400(2):129-43. PubMed ID: 25701352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in colorectal cancer genomics and transcriptomics drive early detection and prevention.
    Lam KK; Thean LF; Cheah PY
    Int J Biochem Cell Biol; 2021 Aug; 137():106032. PubMed ID: 34182137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.
    Mohapatra SS; Batra SK; Bharadwaj S; Bouvet M; Cosman B; Goel A; Jogunoori W; Kelley MJ; Mishra L; Mishra B; Mohapatra S; Patel B; Pisegna JR; Raufman JP; Rao S; Roy H; Scheuner M; Singh S; Vidyarthi G; White J
    Dig Dis Sci; 2018 May; 63(5):1123-1138. PubMed ID: 29572615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics, genomics, and molecular biology in the personalized treatment of colorectal cancer.
    Carethers JM
    J Gastrointest Surg; 2012 Sep; 16(9):1648-50. PubMed ID: 22760966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.
    Sethi MK; Hancock WS; Fanayan S
    Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Personalized medicine--the future is already here].
    Abadi-Korek I; Shemer J
    Harefuah; 2011 May; 150(5):451-2, 490. PubMed ID: 21678641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalizing therapy for colorectal cancer.
    Wong A; Ma BB
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):139-44. PubMed ID: 24025538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized therapy for metastatic colorectal cancer.
    Silvestri A; Pin E; Huijbers A; Pellicani R; Parasido EM; Pierobon M; Petricoin E; Liotta L; Belluco C
    J Intern Med; 2013 Jul; 274(1):1-24. PubMed ID: 23527888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer.
    Aguirre-Portolés C; Fernández LP; Ramírez de Molina A
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28956850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From tumour heterogeneity to advances in precision treatment of colorectal cancer.
    Punt CJ; Koopman M; Vermeulen L
    Nat Rev Clin Oncol; 2017 Apr; 14(4):235-246. PubMed ID: 27922044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers in the treatment of metastatic colorectal cancer.
    Wilson PM; Labonte MJ; Lenz HJ
    Cancer J; 2010; 16(3):262-72. PubMed ID: 20526105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.